Shebani Sethi Dalai MD

Bio:   Dr. Sethi Dalai is double board certified in both Psychiatry and Obesity Medicine. She is an Attending Psychiatrist in the Department of Psychiatry and Behavioral Sciences and Director of Metabolic Psychiatry (https://med.stanford.edu/psychiatry/patient_care/metabolic.html). She has specialized training and expertise in obesity medicine and adult eating disorders. She completed her residency in Psychiatry at Stanford University. Dr. Sethi Dalai received her MD jointly from Duke University School of Medicine and National University of Singapore. She also received a Masters degree in Biotechnology from Johns Hopkins University. Dr. Sethi Dalai’s approach to psychiatric treatment incorporates principles of obesity treatment, metabolic health, and nutrition. She was awarded a grant by the Obesity Treatment Foundation as principal investigator to study the effectiveness of a low - carbohydrate dietary intervention in an outpatient cohort of patients with obesity and bipolar illness or schizophrenia. In addition, she is a co-investigator on a clinical trial testing an FDA approved obesity medication for binge-eating disorder and bulimia nervosa at Stanford University funded by SPARK. She is a recipient of the Symonds Fellow Award from the Association of Women Psychiatrists for innovation in psychiatry and contributions to women’s health. She is a member of the Obesity Medicine Association, the American Psychiatric Association, and served on the council of the Northern California Psychiatric Association.

Professional Education

  • Board Certification, Obesity Medicine, American Board of Obesity Medicine (2020)
  • Board Certification: American Board of Psychiatry and Neurology, Psychiatry (2018)
  • Residency: Stanford University Adult Psychiatry Residency (2017) CA
  • Residency, Stanford University Medical Center, Psychiatry (2017)
  • Internship, Stanford University Medical Center, Psychiatry (2014)
  • MD, National University of Singapore, Medicine (2013)
  • MD, Duke University School of Medicine, Medicine (2013)
  • MS, Johns Hopkins University, Biotechnology (2007)

Honors & Awards

  • ASCP Clinical Trial Scholarship, American Society of Clinical Psychopharmacology (2016)
  • Clinical and Translational Science Award (CTSA) Seed Grant, Stanford Office of Community Health (2010-2012)
  • Obesity Treatment Foundation Grant Award, Obesity Medicine Association (2018)
  • Recipient, The Coaching Fellowship (2015)
  • Scholar, Stanford Society of Physician Scholars (2015)
  • Symonds Fellow Award, Association of Women Psychiatrists (2016)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.